Similar matrix alterations in alveolar and small airway walls of COPD patients

详细信息    查看全文

• 作者：Irene MJ Eurlings ; Mieke A Dentener ; Jack PM Cleutjens…
• 刊名：BMC Pulmonary Medicine
• 出版年：2014
• 出版时间：December 2014
• 年：2014
• 卷：14
• 期：1
• 全文大小：1,456 KB
• 参考文献：1. Mannino, DM, Buist, AS (2007) Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370: pp. 765-773 CrossRef
  2. Ranga, V, Kleinerman, J (1978) Structure and function of small airways in health and disease. Arch Pathol Lab Med 102: pp. 609-617
  3. Hogg, JC, Chu, F, Utokaparch, S, Woods, R, Elliott, WM, Buzatu, L, Cherniack, RM, Rogers, RM, Sciurba, FC, Coxson, HO, Pare, PD (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350: pp. 2645-2653 CrossRef
  4. Araya, J, Cambier, S, Markovics, JA, Wolters, P, Jablons, D, Hill, A, Finkbeiner, W, Jones, K, Broaddus, VC, Sheppard, D, Barzcak, A, Xiao, Y, Erle, DJ, Nishimura, SL (2007) Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients. J Clin Invest 117: pp. 3551-3562 CrossRef
  5. Bolton, SJ, Pinnion, K, Oreffo, V, Foster, M, Pinkerton, KE (2009) Characterisation of the proximal airway squamous metaplasia induced by chronic tobacco smoke exposure in spontaneously hypertensive rats. Respir Res 10: pp. 118 CrossRef
  6. Dekkers, BG, Schaafsma, D, Nelemans, SA, Zaagsma, J, Meurs, H (2007) Extracellular matrix proteins differentially regulate airway smooth muscle phenotype and function. Am J Physiol Lung Cell Mol Physiol 292: pp. L1405-L1413 CrossRef
  7. Kranenburg, AR, Willems-Widyastuti, A, Moori, WJ, Sterk, PJ, Alagappan, VK, de Boer, WI, Sharma, HS (2006) Enhanced bronchial expression of extracellular matrix proteins in chronic obstructive pulmonary disease. Am J Clin Pathol 126: pp. 725-735 CrossRef
  8. Papakonstantinou, E, Karakiulakis, G (2009) The ‘sweet-and ‘bitter-involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance. Br J Pharmacol 157: pp. 1111-1127 CrossRef
  9. van Straaten, JF, Coers, W, Noordhoek, JA, Huitema, S, Flipsen, JT, Kauffman, HF, Timens, W, Postma, DS (1999) Proteoglycan changes in the extracellular matrix of lung tissue from patients with pulmonary emphysema. Mod Pathol 12: pp. 697-705
  10. Harju, T, Kinnula, VL, Paakko, P, Salmenkivi, K, Risteli, J, Kaarteenaho, R (2010) Variability in the precursor proteins of collagen I and III in different stages of COPD. Respir Res 11: pp. 165 CrossRef
  11. Vestbo, J, Hurd, SS, Rodriguez-Roisin, R (2012) An overview of global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (GOLD) (revised 2011). Zhonghua Yi Xue Za Zhi 92: pp. 937-938
  12. Janoff, A (1985) Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis. Am Rev Respir Dis 132: pp. 417-433
  13. Black, PN, Ching, PS, Beaumont, B, Ranasinghe, S, Taylor, G, Merrilees, MJ (2008) Changes in elastic fibres in the small airways and alveoli in COPD. Eur Respir J 31: pp. 998-1004 CrossRef
  14. Annoni, R, Lancas, T, Yukimatsu Tanigawa, R, de Medeiros Matsushita, M, de Morais Fernezlian, S, Bruno, A, Fernando Ferraz da Silva, L, Roughley, PJ, Battaglia, S, Dolhnikoff, M, Hiemstra, PS, Sterk, PJ, Rabe, KF, Mauad, T (2012) Extracellular matrix composition in COPD. Eur Respir J 40: pp. 1362-1373 CrossRef
  15. Karvonen, HM, Lehtonen, ST, Harju, T, Sormunen, RT, Lappi-Blanco, E, Makinen, JM, Laitakari, K, Johnson, S, Kaarteenaho, RL (2013) Myofibroblast expression in airways and alveoli is affected by smoking and COPD. Respir Res 14: pp. 84 CrossRef
  16. Sohal, SS, Reid, D, Soltani, A, Ward, C, Weston, S, Muller, HK, Wood-Baker, R, Walters, EH (2010) Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers wi
• 刊物主题：Pneumology/Respiratory System; Internal Medicine;
• 出版者：BioMed Central
• ISSN：1471-2466

文摘

Background Remodelling in COPD has at least two dimensions: small airway wall thickening and destruction of alveolar walls. Recent studies indicate that there is some similarity between alveolar and small airway wall matrix remodelling. The aim of this study was to characterise and assess similarities in alveolar and small airway wall matrix remodelling, and TGF-β signalling in COPD patients of different GOLD stages. Methods Lung tissue sections of 14 smoking controls, 16 GOLD II and 19 GOLD IV patients were included and stained for elastin and collagens as well as hyaluronan, a glycosaminoglycan matrix component and pSMAD2. Results Elastin was significantly decreased in COPD patients not only in alveolar, but also in small airway walls. Interestingly, both collagen and hyaluronan were increased in alveolar as well as small airway walls. The matrix changes were highly comparable between GOLD stages, with collagen content in the alveolar wall increasing further in GOLD IV. A calculated remodelling index, defined as elastin divided over collagen and hyaluronan, was decreased significantly in GOLD II and further lowered in GOLD IV patients, suggesting that matrix component alterations are involved in progressive airflow limitation. Interestingly, there was a positive correlation present between the alveolar and small airway wall stainings of the matrix components, as well as for pSMAD2. No differences in pSMAD2 staining between controls and COPD patients were found. Conclusions In conclusion, remodelling in the alveolar and small airway wall in COPD is markedly similar and already present in moderate COPD. Notably, alveolar collagen and a remodelling index relate to lung function.